维普中文期刊产品整合服务
217篇 您的检索式:作者名="Muley T"
    题名 作者 年代 出处 被引量
1The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells 显示文摘Crnkovic - Mertens I Muley T Meister M 2006Lung Cancer2006,54,2:1
2Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC显示文摘Ebert W Muley T Trainer C 2002Anticancer Res2002,22,2:1
3The anti-apoptot- ic livin gene is an important determinant for the apoptotic resis- tance of non-small cell lung cancer cells显示文摘Crnkovic-Mertens I Muley T Meister M 2006Lung Cmacer2006,54,2:1
4Pulmonary metastasectomy in patients with soft tissue sarcomas:experiences in 50 patients显示文摘Pfannschmidt J Klode J Muley T 2006Thorac Cardiovasc Surg2006,54,:1
5Comparision of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC 显示文摘Ebert W Muley T Trainer C 2002Auti Cancer Res2002,22,28:1
6Comparison of changes in the NSE levels with clinical assessment in therapy monitoning of patients with SCLC显示文摘Ebert W Muley T Trainer C 2002Anticancer Res2002,22,2:1
7Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC显示文摘Muley T Fetz TH Dienemann H 0,,03:1
8Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process显示文摘Ebert W Muley T Dring p 1996Anticancer Res1996,16,4:1
9Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients显示文摘Ebert W Muley T Herb KP 2004Anticancer Res2004,24,5:1
10Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC 显示文摘Ebert W Muley T Trainer C 2002Anticancer Res2002,22,2:1
11Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma显示文摘Pfannschmidt J Hoffmann H Muley T 2002Ann Thorac Surg2002,74,5:1
12Management of ehylothorax in adults: when is surgery indicated? 显示文摘Zabeck H Muley T Dienemann H 2011Thorac Cardiovasc Surg2011,59,4:1
13Survival afterpulmonary metastasectomy in patients with malignant melanoma显示文摘Schuhan C Muley T Dienemann H Pfannschmidt J 2011Thorac Cardiovasc Surg2011,59,3:1
14CYFRA21-1 in the follow-up of inoperable nonsmall cell lung cancer patients treated with chemotherapy 显示文摘Ebert W Muley T 1999Anticancer Res1999,19,:1
15Treatment and outcome of pa- tients with metastatic NSCLC: a retrospective institution analysis of 493 patients显示文摘Reinmuth N Payer N Muley T 2013Respir Res2013,14,:1
16Primary tracheal tumors:experience of 14 resected patients显示文摘Schneider P Schirren J Muley T 2001Eur J Cardiothorac Surg2001,20,1:1
17Prognostic assessmentafter surgical resection for non-small cell lung cancer; experiencesin 2083 patients显示文摘Pfannschmidt J Muley T Bulzebruck H 2007Lung Cancer2007,55,3:1
18The anti-apoptotic Livin gene is an important determinant for the apoptotic resistance of non-small eel1 lung cancer cells 显示文摘Crnkovic MI Muley T Meister M 2006Lung Cancer2006,54,2:1
19Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients 显示文摘Ebert W Muley T Herb K P 2004Anticancer Res2004,24,:1
20Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma:experiences in 167 patients显示文摘Pfannschmidt J Muley T Hoffmann H 0,,:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费